Literature DB >> 11544350

Toxic shock syndrome and bacterial superantigens: an update.

J K McCormick1, J M Yarwood, P M Schlievert.   

Abstract

Toxic shock syndrome (TSS) is an acute onset illness characterized by fever, rash formation, and hypotension that can lead to multiple organ failure and lethal shock, as well as desquamation in patients that recover. The disease is caused by bacterial superantigens (SAGs) secreted from Staphylococcus aureus and group A streptococci. SAGs bypass normal antigen presentation by binding to class II major histocompatibility complex molecules on antigen-presenting cells and to specific variable regions on the beta-chain of the T-cell antigen receptor. Through this interaction, SAGs activate T cells at orders of magnitude above antigen-specific activation, resulting in massive cytokine release that is believed to be responsible for the most severe features of TSS. This review focuses on clinical and epidemiological aspects of TSS, as well as important developments in the genetics, biochemistry, immunology, and structural biology of SAGs. From the evolutionary relationships between these important toxins, we propose that there are five distinct groups of SAGs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544350     DOI: 10.1146/annurev.micro.55.1.77

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  237 in total

1.  Characterization of Staphylococcus aureus enterotoxin L.

Authors:  Paul M Orwin; J Ross Fitzgerald; Donald Y M Leung; Juan A Gutierrez; Gregory A Bohach; Patrick M Schlievert
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  The zinc-dependent major histocompatibility complex class II binding site of streptococcal pyrogenic exotoxin C is critical for maximal superantigen function and toxic activity.

Authors:  Timothy J Tripp; John K McCormick; Jennifer M Webb; Patrick M Schlievert
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  Global repression of exotoxin synthesis by staphylococcal superantigens.

Authors:  Nikola Vojtov; Hope F Ross; Richard P Novick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

4.  Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatment.

Authors:  J M Langley; C M Soder; P M Schlievert; S Murray
Journal:  Can Fam Physician       Date:  2003-07       Impact factor: 3.275

Review 5.  Bacterial superantigens.

Authors:  T Proft; J D Fraser
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

6.  Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.

Authors:  P D Fey; B Saïd-Salim; M E Rupp; S H Hinrichs; D J Boxrud; C C Davis; B N Kreiswirth; P M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

7.  Caspase inhibitors attenuate superantigen-induced inflammatory cytokines, chemokines, and T-cell proliferation.

Authors:  Teresa Krakauer
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

8.  Biological properties of staphylococcal enterotoxin-like toxin type R.

Authors:  Katsuhiko Omoe; Ken'ichi Imanishi; Dong-Liang Hu; Hidehito Kato; Hiromi Takahashi-Omoe; Akio Nakane; Takehiko Uchiyama; Kunihiro Shinagawa
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Peptide antagonists of superantigen toxins.

Authors:  Raymond Kaempfer
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

10.  Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.

Authors:  Patrick M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.